President Trump signed an executive order on May 29, 2026, directing the U.S. Centers for Disease Control and Prevention (CDC) to adopt vaccine recommendations aligned with a recent Department of Health and Human Services (HHS) assessment that advocates for fewer childhood vaccines.
What happened
This order follows an HHS report published in January that found the United States recommends more childhood vaccines than any peer developed nation, including more than twice as many doses as those recommended in some European countries. After the report, the CDC updated its guidelines to reduce the recommended immunizations for children from 17 to 11 diseases.
The CDC’s January recommendations specify that immunizations for diseases such as respiratory syncytial virus (RSV), hepatitis A and B, dengue, and some meningococcal strains should be prioritized only for children at high risk. Vaccines retained in the schedule include measles, mumps, rubella, pertussis, tetanus, diphtheria, Haemophilus influenzae type b, pneumonia, polio, human papillomavirus (HPV), and varicella (chickenpox).
The order also instructs the CDC’s Advisory Committee on Immunization Practices (ACIP) to review the HHS assessment and the latest clinical data and update the U.S. childhood and adolescent vaccine schedules accordingly.
The White House described the executive order as a reaffirmation of commitment to scientific standards and greater flexibility for patients and doctors.
Why it matters
The executive order represents a significant shift in U.S. public health policy concerning childhood immunizations. By reducing recommended vaccines, the federal government is responding to critiques that the current U.S. schedule exceeds what is necessary compared to other developed countries.
However, this policy shift has faced strong opposition from medical experts and organizations such as the American Academy of Pediatrics (AAP), which issued its own vaccine guidance diverging from the CDC’s revised recommendations. Critics have questioned the scientific basis and safety implications of reducing vaccine coverage.
The controversy also highlights challenges in public trust and the balance between vaccine accessibility, patient choice, and public health protection amid diverse epidemiological contexts in the U.S. compared to other nations.
Background
The directive follows an earlier memo from President Trump in December 2025 ordering HHS to benchmark U.S. childhood vaccine recommendations against those of peer developed countries. The HHS then released a scientific assessment recommending fewer vaccines.
Subsequently, the CDC’s ACIP—reconstituted under Health Secretary Robert F. Kennedy Jr., who has expressed vaccine skepticism—made changes including delaying the first dose of hepatitis B vaccine from birth to two months for certain infants. This change deviated from longstanding guidelines.
A federal judge later ruled against the legality of the new ACIP member appointments and the altered vaccine schedule, finding that the administration bypassed the traditional scientific review process.
Public health experts argue that vaccine recommendations are tailored to country-specific disease risks and healthcare systems, cautioning against direct comparisons with other nations.
Sources
This article is based on reporting and publicly available information from the following source:
Read more US News stories on Goka World News.